Literature DB >> 13932273

Chlorpromazine-induced weakness in myasthenia gravis.

M P MCQUILLEN, M GROSS, R J JOHNS.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE; MYASTHENIA GRAVIS

Mesh：

Substances：

Year:  1963        PMID： 13932273     DOI： 10.1001/archneur.1963.00460030070006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  4 in total

1.  [The effect of chlorpromazine on inhibitory processes in the spinal cord of patients with spastic paralyses].

Authors:  S Baykuschev
Journal:  Dtsch Z Nervenheilkd       Date:  1968

2.  Thyrotoxic crisis and transient myasthenia gravis in pregnancy.

Authors:  P Horrocks; J C Leonard
Journal:  Postgrad Med J       Date:  1966-01       Impact factor: 2.401

3.  MYASTHENIA GRAVIS: MEDICAL ASPECTS.

Authors:  L R ZELDOWICZ; W S BUCKLER
Journal:  Can Med Assoc J       Date:  1965-07-31       Impact factor: 8.262

Review 4.  Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.

Authors:  Isin Baral Kulaksizoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.